Lampit and Alcohol/Food Interactions
There is 1 alcohol/food/lifestyle interaction with Lampit (nifurtimox).
Nifurtimox Food
Major Food Interaction
CONTRAINDICATED: Use of alcohol or products containing alcohol during therapy with nitrofurans may result in a disulfiram-like reaction in some patients. The presumed mechanism is inhibition of aldehyde dehydrogenase (ALDH) by nitrofurans in a manner similar to disulfiram. Following ingestion of alcohol, inhibition of ALDH results in increased concentrations of acetaldehyde, the accumulation of which can produce an unpleasant physiologic response referred to as the 'disulfiram reaction'. Symptoms include flushing, throbbing in head and neck, throbbing headache, respiratory difficulty, nausea, vomiting, sweating, thirst, chest pain, palpitation, dyspnea, hyperventilation, tachycardia, hypotension, syncope, weakness, vertigo, blurred vision, and confusion. Severe reactions may result in respiratory depression, cardiovascular collapse, arrhythmia, myocardial infarction, acute congestive heart failure, unconsciousness, convulsions, and death.
ADJUST DOSING INTERVAL: Food enhances the oral bioavailability of nifurtimox. When a single 120 mg oral dose of nifurtimox was administered with a high-fat meal (800 to 1000 calories; approximately 60% fat) in adult Chagas patients, nifurtimox peak plasma concentration (Cmax) and systemic exposure (AUC) increased by 68% and 71%, respectively, compared to administration under fasted conditions. Nifurtimox was administered with food in clinical trials.
MANAGEMENT: Consumption of alcohol is considered contraindicated during nifurtimox therapy. To ensure maximal oral absorption, nifurtimox should be administered with food.
References (1)
- (2020) "Product Information. Lampit (nifurtimox)." Bayer Pharmaceutical Inc
Switch to consumer interaction data
Lampit drug interactions
There are 12 drug interactions with Lampit (nifurtimox).
Lampit disease interactions
There are 5 disease interactions with Lampit (nifurtimox) which include:
More about Lampit (nifurtimox)
- Lampit consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antibiotics
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.